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Abstract
Background: Prognosis estimates are used to access services, but are often inaccurate. This study
aimed to determine the accuracy of giving a prognosis range.
Methods and measurements: A prospective cohort study in four multi-professional palliative
care teams in England collected data on 275 consecutive cancer referrals who died. Prognosis
estimates (minimum – maximum) at referral, patient characteristics, were recorded by staff, and
later compared with actual survival.
Results: Minimum survival estimates ranged <1 to 364 days, maximum 7 – 686 days. Mean patient
survival was 71 days (range 1 – 734). In 42% the estimate was accurate, in 36% it was over optimistic
and in 22% over pessimistic. When the minimum estimate was less than 14 days accuracy increased
to 70%. Accuracy was related, in multivariate analysis, to palliative care team and (of borderline
significance) patient age.
Conclusions: Offering a prognosis range has higher levels of accuracy (about double) than
traditional estimates, but is still very often inaccurate, except very close to death. Where possible
clinicians should discuss scenarios with patients, rather than giving a prognosis range.
Background
Doctors are commonly asked 'how long have I got?'. But
prognostic error is widespread, only around 20% of esti-
mates are accurate [1,2]. Errors of both optimism and pes-
simism occur; the former is more common, in one study
63% of 468 estimates were optimistic [3]. Doctors and
other health care professionals are not trained in prognos-
tication even though they may need this information to
plan future care, particularly referral to hospice care or for
other benefits. Prognostic information can be very impor-
tant for patients and families in decision making, if they
wish to organise their affairs or plan special meetings,
trips or events [4,5]. Younger patients often want full in-
formation [6]. Predictive indices, developed to improve
estimates of shorter survival, have included factors such
as: falling functional status, as indicated by the Karnofsky
or Bartell index [7], asthenia [8], weight loss, cognitive
failure, dysphagia [9], high total white blood cell count,
low lymphocyte percentage and low pseudocholineste-
rase [10]. However, their sensitivity and specificity is poor.
One way of dealing with the difficulties in prognostica-
tion is to discuss a possible range of scenarios and surviv-
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al. But we do not know whether giving a prognosis range
improves accuracy, and, if it does, by how much. In this
study we tested the accuracy of giving an estimated range
of prognosis, rather than a specific point in time.
Methods
Design
Prospective cohort study, as part of a larger assessment of
palliative care [11,12].
Setting
Four multi-professional palliative care teams in the South
of England, UK. Teams worked either in home care and/
or hospitals [11]. Teams Z and W were basedin the com-
munity, but both saw patients in hospitals as well. Teams
Y and X were based in acute hospitals but also cared for
patients who were at home. All teams included nurses (to-
tal 10 full-time equivalent nurses, team Z - 2, Y - 3, X - 2,
W - 3) all ofwhom had been trained in palliative care.
Some also had oncology and community nurse training.
Two teams (Z and W) had their own physicians (1 full-
time physician, team Z, 0.6 team W) who visited patients
both in hospital and at home, but Y and X (the hospital-
based teams) had support from physicians working with-
in the hospital. Teams Z and W also had social workers as
part of the team.
Patients
409 consecutive patient referrals known to have died at
follow-up one year after the end of the study.
Measurements
After their first full assessment of the patient, the team
members gave an estimate of minimum and maximum
prognosis. The instructions were simply to estimate the
boundaries of minimum to maximum survival. No limit
to the range was defined. Team members could refuse to
give an estimate if they felt very unsure – which was re-
corded no estimate given. The key worker assigned to the
patient, usually a nurse, made the estimate. This was then
usually discussed at the team meeting
Analysis
First, we compared the characteristics and survival of
those patients with and without estimates. Then, for those
with estimates, the prediction of survival was defined as
accurate if survival fell between minimum and maximum
estimates. Associations between possible explanatory var-
iables and accuracy were examined using, in the univari-
ate analysis, chi-square tests. To evaluate the independent
role of each variable after adjusting for all the others, a
multivariate logistic regression model was fitted to the da-
ta.
Results
Of the 409 patients, for 133 (33%) no survival estimates
were given, and for 1 a minimum prognosis was missing,
leaving 275 patients with estimates. There were significant
differences between teams in whether they gave a survival
estimate, with team W recording an estimate in 93% of
cases and team X recording an estimate in only 20% (ta-
ble). There was slightly shorter survival among patients
without estimates, but this did not reach significance. No
other differences in patient characteristics were detected.
Of the 275 patients with estimates, all had cancer, with a
mean age of 66 years (median 67, range 32–92), 52%
were male, 61% were married, 28% had cancers of the
lung, 31% of gastro-intestinal tract, 12% genito-urinary,
9% breast, 4% lymphatic or haemopoetic, 8% primary
unknown, 8% others.
Minimum survival estimates ranged from <1 to 364 days
(median 28 days), and maximum from 7 to 686 days (me-
Figure
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actual survival.
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dian 84 days). The mean range between minimum and
maximum estimates was 57 days, median 42 (range 6–
504). Mean actual patient survival was 71 days; median
42 (range 1–734). In 115 patients (42%) the predicted
range was accurate (falling between minimum and maxi-
mum estimates), in 100 (36%) the minimum was over
optimistic; and 60 (22%) lived longer that the maximum
estimate (see figure).
The minimum estimate was closer to actual survival than
the maximum estimate in many, but not all, instances (see
figure). The median (range) difference between survival
and the minimum estimate (i.e. survival-minimum esti-
mate) was 5 days, but there was a wide range from -156 to
491. Thus, many minimum estimates were close to actual
survival and, on average, were 5 days shorter. However, in
the most extreme case (-156), the team estimated a mini-
mum survival of 175 days but the patient survived 19
days. The median (range) difference between the maxi-
mum estimate and survival (i.e. maximum estimate-sur-
vival) was 29 days (-360 to 572). Thus, in the most
extreme case (-360), the team estimated a maximum sur-
vival of 168 days but the patient survived 528 days.
Accuracy did not appear to be related to gender, status
(married or not), whether there was a lay caregiver or their
relationship to the patient, or the size of the prognosis
range, from minimum to maximum. In univariate analy-
sis accuracy was significantly related to: diagnosis (chi-
squared, 9.6, df 4, p < 0.05, accuracy was lowest (24%) for
breast cancer patients and was similar for all the others)
and palliative care team (chi-squared, 32.2, df 6, p <
0.0001, accuracy was; Z - 33%, Y - 78% X - 15%, W - 42%).
Although the least accurate team (X) completed the small-
est proportion of survival estimates, further exploration of
the team data found no consistent relationship between
Table 1: Comparison of the characteristics of those patients with and without prognosis estimates. The percentages are row percent-
ages. Test results are given when P < 0.2. NS = Not significant.
prognosis estimates NO n = 134 prognosis estimates YES n = 275 test results-always chi-square unless 
specified
N. (%) N. (%)
TEAM Z 45 28 118 72
Y 2 84 33 75 7
X 5 38 01 32 0
W 8 7 107 93 107,6; DF 3, p < 0.001
AGE (mean ± DS) 66.5 ± 9.7 65.9 ± 11.4 NS
(median; range) 67(32–87) 67(32–92)
GENDER
males 77 35 144 65
females 57 30 131 70 NS
PRIMARY TUMOUR
lung 33 30 76 70
GI 31 27 85 73
GU 27 45 33 55
breast 13 34 25 66
others 26 32 56 68 6,37; DF 4; p = 0.173
STATUS
married 78 32 167 68
single 51 32 107 68 NS
CARER
no carer 2 15 11 85
lay carer (wife, husband ...) 109 32 234 68
other (friend, other) 15 34 29 66 NS
SURVIVAL
(mean ± DS) 54.3 ± 57.9 71.3 ± 92.5
(median; range) survival (categories) 33.5 (1–311) 42 (1–734) p = 0.176 (M-Whitney test)
1–21 49 35 89 65
22–60 43 34 84 66
61–90 16 32 34 68
91–180 17 29 41 71
>180 9 25 27 75 1,78; DF 1 (trend); p 0.183BMC Palliative Care 2002, 1 http://www.biomedcentral.com/1472-684X/1/1
Page 4 of 5
(page number not for citation purposes)
accuracy and the proportion of missing estimates. Howev-
er, the most accurate team (Y) cared for patients with the
shortest survivals; survival among the other three teams
was similar.
There was a trend of reducing accuracy with increasing pa-
tient age (chi-squared for trend, 5.0, df 1, p = 0.025, from
52% accuracy in those aged < 55 years, to 31% in those
over 75). Accuracy was better in those cases when the min-
imum estimate was lower (chi-squared, 35.2, df 4, p <
0.001, accuracy was 70% in cases where the minimum es-
timate was 2 weeks or less). Similar trends were found for
the maximum estimate and for survival (although clearly
the latter can not be used prospectively).
The logistic model was fitted to the data by including: pal-
liative care teams (3 df), diagnoses (4 df), age (1 df) and,
to adjust for case-mix, survival. After adjusting for all these
variables, only palliative care teams (p = 0.001) remained
significantly associated with accuracy of prediction, age
was borderline, (p = 0.054), and the association with the
diagnosis observed in the univariate analysis disappeared
(p = 0.192).
Discussion
One criticism of the study is that the team members had
little time to get to know the patient. Had we recorded es-
timates later in care, they might have been better. Howev-
er, a strong doctor-patient relationship is associated with
lower prognosis accuracy and prognostic accuracy is high-
er in more experienced professionals [3]. All of the staff in
this study were professionals working in palliative care for
some time. Therefore, the staff in this study should be
among the most accurate.
The team members gave best guesses about their patient's
survival prospects. These were communicated to the in-
vestigators, and not to the patients themselves, unless the
patient asked for information about prognosis, when a
sensitive discussion with the team member followed. In a
significant proportion of cases (33%), team members
were reluctant to give estimates at all, indicating their own
uncertainty in this field and the growing opinion that
prognosis estimates were dangerous because of error.
Staff varied in their willingness to provide estimates. One
team provided estimates on only 20% of patients, where-
as another team provided estimates on over 90%. Willing-
ness to provide estimates did not appear to be related to
team characteristics, presence of a doctor, home or hospi-
tal based, or accuracy. Nor was it related to patient charac-
teristics. Our discussions with the teams suggested it was
more of a philosophical stance of some staff. It may be
that if we had asked the question in a different way, for ex-
ample: 'would you be surprised if..X.. was alive before or after
these dates..' we could have found higher completion rates.
However, in some instances staff are required to provide
survival estimates. Eligibility for some health care and
benefits, for example, Medicare Hospice Benefit in the
USA, admission to some hospice programs in Italy and
the welfare benefit 'Attendance Allowance' in the UK, is
dependent on an estimated prognosis of less than six
months. We found that these experienced palliative care
staff, primarily nurses, giving a range, had higher levels of
accuracy than in earlier studies of doctors or other staff.
Gross over-optimism was less common. However, in 58%
of cases, the range was wrong. This is likely to be an upper
bound to their accuracy, because in one third of patients
the team refused to record an estimate. Sensitivity analy-
sis, including these unrecorded estimates as all either 'in-
accurate' or 'accurate', would give a range of 28 – 61%
accuracy. It is likely that true accuracy is in the range of 28
– 58%, as estimation is likely to be more difficult among
those patients where survival was unrecorded.
Estimates tended to be less accurate among older patients.
This may be due to the difficulties of multiple health
problems in older patients. It might also be one cause of
the disadvantaged access of older people to hospice and
palliative care services [13,14]. Despite the relative homo-
geneity of the teams, differences in accuracy existed and
remained after adjusting for the other variables in the lo-
gistic model. This suggests that it may be possible to im-
prove estimates with training and experience. During the
study, IJH observed that some team members began to
change practice. The following quote from one team
member, noted during the study, illustrates this: 'about
two months ago when I saw a patient, I would think of my
normal minimum estimate and then halve it, because I
got so many over. But I think that is still too long. So now
I take my minimum estimate, halve it, and halve it again,
and that's what I write down'. Other team members may
have done this, without the investigators knowledge. It
may be that monitoring and estimating prognosis esti-
mates and feeding this information back within the team
may be an important part of improving practice. This war-
rants further study. Further research is needed to identify
more reliable prognostic indicators, to identify the fea-
tures of a more accurate estimate or assessor and instances
when assessments should or should not be made.
This finding supports earlier work, that prognosis esti-
mates are unreliable and best avoided. However, a range
is slightly better than a one point estimate. Estimates be-
came only slightly more reliable (70%) when the mini-
mum survival estimate was less than 2 weeks. This finding
may explain why the median survival after enrollment to
hospice care in the USA, where a prognosis estimate is aBMC Palliative Care 2002, 1 http://www.biomedcentral.com/1472-684X/1/1
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criteria for admission, is 36 days [15], and falling, al-
though a few patients live for longer than one year.
We suggest that if asked about prognosis, we should ac-
knowledge their likely inaccuracies, explore reasons for
needing one, discuss possible scenarios and appropriate
indications to reappraise the situation, and if appropriate
consult with more experienced clinicians. However, this
approach would bring into question the criteria for eligi-
bility for palliative and hospice care in many countries.
The consistent trend to over estimate survival and there-
fore delay referral based on these guidelines may be one
reason why such short median survivals are observed by
palliative care teams. Perhaps short survival after referral
should become a negative quality control outcome, since
patients with very short survival have very limited access
for themselves or their families to the benefits of palliative
care teams. Our work supports calls for new eligibility cri-
teria for service access, not reliant highly unreliable prog-
nosis estimates of six months or less [16,17]. We propose,
a more flexible approach is required, centered on a patient
and family's condition, needs and likelihood of benefit.
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